Turnstone Biologics Corp. financial data

Symbol
TSBX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
9310 Athena Circle, Suite 300, La Jolla, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 476 %
Debt-to-equity 25.6 %
Return On Equity -132 % -105%
Return On Assets -105 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 23.1M shares +0.17%
Common Stock, Shares, Outstanding 23.1M shares +0.16%
Entity Public Float 44.9M USD
Common Stock, Value, Issued 23K USD 0%
Weighted Average Number of Shares Outstanding, Basic 23M shares +99.2%
Weighted Average Number of Shares Outstanding, Diluted 23M shares +99.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 56.1M USD -7.25%
General and Administrative Expense 16.4M USD -8.16%
Operating Income (Loss) -72.5M USD -22.8%
Nonoperating Income (Expense) 1.69M USD -52.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -70.8M USD -27.6%
Income Tax Expense (Benefit) 37K USD
Net Income (Loss) Attributable to Parent -70.8M USD -28.3%
Earnings Per Share, Basic -3.07 USD/shares
Earnings Per Share, Diluted -3.07 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 28.9M USD +62.5%
Cash, Cash Equivalents, and Short-term Investments 77.8M USD
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Other Assets, Current 1.99M USD -29.3%
Assets, Current 34.2M USD -66.6%
Property, Plant and Equipment, Net 4.18M USD -34.3%
Operating Lease, Right-of-Use Asset 933K USD -66.3%
Other Assets, Noncurrent 811K USD -29%
Assets 40.1M USD -64.4%
Accounts Payable, Current 870K USD +2317%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 8.2M USD -31.5%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 104K USD -91.3%
Other Liabilities, Noncurrent 369K USD -62.7%
Liabilities 8.67M USD -38.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -202K USD -69.7%
Retained Earnings (Accumulated Deficit) -248M USD -40.1%
Stockholders' Equity Attributable to Parent 31.5M USD -68.1%
Liabilities and Equity 40.1M USD -64.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17.5M USD -1.69%
Net Cash Provided by (Used in) Investing Activities 14.1M USD -14.6%
Common Stock, Shares Authorized 490M shares 0%
Common Stock, Shares, Issued 23.1M shares +0.16%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.37M USD -127%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 29M USD +62.1%
Deferred Tax Assets, Valuation Allowance 62.4M USD +33.4%
Deferred Tax Assets, Gross 62.8M USD +30.6%
Operating Lease, Liability 1.19M USD -63%
Payments to Acquire Property, Plant, and Equipment 144K USD -83.6%
Lessee, Operating Lease, Liability, to be Paid 1.21M USD -63.7%
Property, Plant and Equipment, Gross 12.1M USD -7.59%
Operating Lease, Liability, Current 1.09M USD -46.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 104K USD -90.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.11M USD -48%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 25K USD -81.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD -100%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 3.6M USD +64%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD
Additional Paid in Capital 279M USD +1.35%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.8M USD -35.7%
Share-based Payment Arrangement, Expense 3.68M USD -12.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%